In patients with gastric cancer, elevated peripheral blood levels of certain CD4+ T cell subpopulations, including Th22 (CD4+IL-22+IL-17−IFN-γ−) and Th17 cells were found to be associated with increased tumor progression [154]. The gene discussed is CD4; the disease is neoplasm.